TABLE 2.
Sample | α | β | Turn | Random |
---|---|---|---|---|
% | % | % | % | |
Aβ1–42 alone | 7.8 | 22.4 | 20.6 | 49.2 |
+ Deoxycholatea | 0.1 | 56.4 | 16.4 | 27.1 |
+Octyl Thioglucosidea | 0 | 53.7 | 17.1 | 29.2 |
+ Fos-Choline 8a | 3.8 | 47.4 | 21.1 | 27.7 |
+ Thesita | 15.2 | 33.6 | 19.9 | 31.3 |
+ N-Decanoyl sucrosea | 3.2 | 47.3 | 18.8 | 30.7 |
+ CYMAL 2a | 16.3 | 26.5 | 20.1 | 37.1 |
+ C13E8b | 58.1 | 5.4 | 20.1 | 16.4 |
+ LDAOb | 65.2 | 6.3 | 16.4 | 12.1 |
+ Fos-Choline 10b | 51.2 | 3.5 | 22.4 | 22.9 |
+ MEGA-8b | 55.3 | 3.9 | 15.6 | 25.2 |
+ CycloFos-Choline 3b | 54.2 | 4.7 | 19.1 | 32 |
+ CYMAL 3b | 45.3 | 15.3 | 19.2 | 20.2 |
a Indicates activating compounds.
b Indicates inhibitory compounds.